According to the report published by Zion Market Research, global demand for biological safety testing market was valued at approximately USD 2,200 Million in 2019, and is expected to generate revenue of around USD 4,658 Million by end of 2026, growing at a CAGR of around 12.5% between 2020 and 2026.
According to the report published by Zion Market Research, global demand for biological safety testing market was valued at approximately USD 2,200 Million in 2019, and is expected to generate revenue of around USD 4,658 Million by end of 2026, growing at a CAGR of around 12.5% between 2020 and 2026.
Global Biological Safety Testing Market: Overview
Biologics are products made from living organisms and has a unique set of properties. Safety of biologics is of utmost importance and specialized evaluation of the same is necessary. Biological safety testing is important for launching new products. Biological safety testing is done in order to ensure the safety quality and non-contamination of vaccines and biopharmaceuticals and to comply with the regulations for the same. Some of the major biological tests are sterility testing, residual host contaminant detection tests, bioburden testing and endotoxin tests. Biological safety testing is used in cellular, vaccine and gene therapy products, tissue and tissue products, blood and blood products and others. Better living standards, increased funding for life science research and rising number of pharmaceutical and biological firms are major factors which have been driving the biological safety testing market globally.
Global Biological Safety Testing Market: Growth Factors
Rising number of pharmaceutical and biological firms, increase in government and private funds and growing number of biologics products are some of the major factors driving the biological safety testing market globally. Growth in the biological safety testing market will also be visible owing to a strong pharmaceutical product pipeline and increasing support from government for biological and pharmaceutical industries. Regulatory bodies are working towards enforcing important standards for biological safety to ensure patient’s safety. Hence, biological safety testing market has a growing importance and has a potential for growth in the coming future. However, stringent regulations and the complicated procedure to obtain FDA approval may act as a restraining factor for the biological safety testing market.
Global Biological Safety Testing Market: Segmentation
The global biological safety testing market is segmented into its product, type of test, application, and geography. Based on the product, the biological safety testing market is divided into instruments, services and kits and reagent. Based on the type of test, the segregation is seen as adventitious agents detection test, cell line authentication and characterization tests, bioburden testing, endotoxin tests, sterility testing, residual host contaminant detection tests and other tests such as efficacy tests, stability tests, and toxicity test. On the basis of application, the market segmentation is seen into blood and blood products, stem cell products, cellular and gene therapy products, tissues and tissue products and vaccines and therapeutics. Regional diversification is seen into Asia, North America, Europe and Rest of the World.
Global Biological Safety Testing Market: Regional Analysis
Geographically, the global biological safety testing market is segmented as North America, Europe, Asia Pacific, and Rest of the World. North America is the largest contender in biological safety testing market. Countries such as Canada and the U.S. have the major markets in the North American region. Rising demand for biological safety testing market is also seen in Asia Pacific region, especially in countries such as China, Japan and India. China and India are the fastest growing market in the Asia Pacific region. Demand for biological safety testing is seen to be steadily rising in Europe as well.
Global Biological Safety Testing Market: Competitive Players
Some of the major companies in the biological safety testing market are Charles River Laboratories International Inc., Sigma-Aldrich Corporation, Lonza Group, SGS SA, Avance Biosciences Inc., WuXiPharmaTech Inc., BSL Bioservice, Merck KGaA, Cytovance Biologics Inc., and Toxikon Corporation.
Global Biological Safety Testing Market: Regional Segment Analysis
Rising number of pharmaceutical and biological firms, increase in government and private funds and growing number of biologics products are some of the major factors driving the biological safety testing market globally.
According to Zion Market Research, global demand for biological safety testing market is expected to generate revenue of around USD 4,658 Million by end of 2026, growing at a CAGR of around 12.5 % between 2020 and 2026.
North America is the largest contender in biological safety testing market. Countries such as Canada and the U.S. have the major markets in the North American region.
Corporate Office
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651
Asia Pacific Office
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No 020-46277770
Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.